The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus
- PMID: 21997966
- DOI: 10.1177/0961203311418789
The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus
Abstract
The Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) is a newly described tool used to assess the activity of and damage caused by cutaneous lupus erythematosus (CLE). There is a paucity of data on CLASI from the Indian subcontinent. We sought to determine the applicability of CLASI in specific lesions of CLE in patients with systemic lupus erythematosus (SLE) attending a tertiary care hospital in India. In this prospective, cross-sectional study, 93 patients of SLE with cutaneous lesions were recruited. CLASI activity and damage scores of lupus erythematosus (LE)-specific skin lesions were done in 75 patients with SLE. The mean CLASI activity score was 15.4 ± 9.4 (range 0-39) and the mean damage score was 6.87 ± 7.75 (range 0-30). Higher mean CLASI activity scores were seen in patients with a combination of acute, subacute and chronic CLE and in those with widespread lesions. Patients with longstanding disease and long duration of skin lesions had higher damage scores. This study shows that CLASI is an effective tool to assess cutaneous activity of LE-specific lesions, and the damage caused by them, in Indian patients.
Similar articles
-
Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI.J Eur Acad Dermatol Venereol. 2011 Jun;25(6):652-9. doi: 10.1111/j.1468-3083.2010.03844.x. Epub 2010 Sep 16. J Eur Acad Dermatol Venereol. 2011. PMID: 20849444
-
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus.Br J Dermatol. 2010 Jul;163(1):83-92. doi: 10.1111/j.1365-2133.2010.09799.x. Epub 2010 Apr 12. Br J Dermatol. 2010. PMID: 20394621
-
Clinicohistological and immunopathological features of patients with cutaneous lupus erythematosus at tertiary dermatology centre in Malaysia.Clin Exp Dermatol. 2022 Aug;47(8):1490-1501. doi: 10.1111/ced.15190. Epub 2022 May 23. Clin Exp Dermatol. 2022. PMID: 35315538
-
Involvement of scalp and nails in lupus erythematosus.Lupus. 2010 Aug;19(9):1078-86. doi: 10.1177/0961203310373938. Lupus. 2010. PMID: 20693201 Review.
-
A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.Lupus. 2013 Jul;22(8):839-46. doi: 10.1177/0961203313492242. Epub 2013 Jun 11. Lupus. 2013. PMID: 23761100 Review.
Cited by
-
Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept Study.Dermatol Reports. 2015 Mar 16;7(1):5804. doi: 10.4081/dr.2015.5804. eCollection 2015 Mar 16. Dermatol Reports. 2015. PMID: 25918617 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical